Centene vs ResMed
Centene (CNC), health care, and ResMed (RMD), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Centene is worth $35.9B on the stock market and ResMed $33.5B: Centene is valued at 7% more. Centene trades at 24.9 times earnings and ResMed at 21.7; operating margins in their latest fiscal years were -3.91% and 33.4%. Over the past year Centene's share price has moved +102% and ResMed's -3.26%.
Key facts
- Centene market value
- $35.9B
- ResMed market value
- $33.5B
- Centene P/E
- 24.9
- ResMed P/E
- 21.7
- Centene revenue
- $194.8BFY to 2025-12-31
- ResMed revenue
- $5.7BFY to 2026-06-30
- Superinvestors holding both
- 0
Market values as of .
| Measure | Centene | ResMed |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2026-06-30 |
| Size | ||
| Market cap | $35.9Bhigher | $33.5Blower |
| Revenue | $194.8Bhigher | $5.7Blower |
| Earnings | -$6.7Blower | $1.5Bhigher |
| Employees | 61,100higher | 11,370lower |
| Total assets | $76.7Bhigher | $9Blower |
| Valuation | ||
| P/E | 24.9higher | 21.7lower |
| P/S | 0.2lower | 5.9higher |
| P/B | 1.6lower | 5.6higher |
| Dividend yield | 0.00%lower | 1.03%higher |
| Profitability | ||
| Operating margin | -3.91%lower | 33.4%higher |
| Balance sheet | ||
| Net assets | $20Bhigher | $6.6Blower |
| Total liabilities | $56.7Bhigher | $2.4Blower |
| Total debt | $17.5Bhigher | $659.4Mlower |
| Cash on hand | $17.9Bhigher | $1.5Blower |
| Price change | ||
| Today | -2.97%lower | -0.14%higher |
| 1 year | +102%higher | -3.26%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Percentages are each holding's share of that investor's reported portfolio. Who owns CNC · Who owns RMD
More on Centene
Further comparisons
Centene against its closest peers
ResMed against its closest peers
Learn
Questions and answers
Which is bigger, Centene or ResMed?
By market value, Centene is the larger: $35.9B against $33.5B for ResMed. By revenue in its latest fiscal year, Centene is the larger: $194.8B against $5.7B for ResMed.
Which has the higher P/E ratio?
Centene: 24.9, against 21.7 for ResMed. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
ResMed: 33.4%, against -3.91% for Centene. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
ResMed: 1.03%, against 0.00% for Centene. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Centene: $17.5B, against $659.4M for ResMed. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Centene and ResMed?
None of the tracked superinvestors holds both in their latest 13F filing. 11 hold Centene and 1 holds ResMed.
Cite this page
Funkfolio, “Centene vs ResMed”, data as of 17 November 2026. https://funkfolio.com/compare/cnc-vs-rmd
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.